1. Home
  2. SOMN vs WGSWW Comparison

SOMN vs WGSWW Comparison

Compare SOMN & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern Company (The) 2025 Series A Corporate Units

SOMN

Southern Company (The) 2025 Series A Corporate Units

N/A

Current Price

$53.26

Market Cap

0.0

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGSWW

GeneDx Holdings Corp.

N/A

Current Price

$0.01

Market Cap

0.0

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SOMN
WGSWW
Founded
1946
2017
Country
United States
United States
Employees
N/A
1300
Industry
Metal Mining
Retail: Computer Software & Peripheral Equipment
Sector
Basic Materials
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SOMN
WGSWW
Price
$53.26
$0.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
250.3K
61.3K
Earning Date
01-01-0001
02-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$305,450,000.00
Revenue This Year
$8.18
N/A
Revenue Next Year
$5.61
N/A
P/E Ratio
$22.48
N/A
Revenue Growth
N/A
50.79
52 Week Low
$47.87
$0.01
52 Week High
$53.99
$0.29

Technical Indicators

Market Signals
Indicator
SOMN
WGSWW
Relative Strength Index (RSI) 58.40 34.65
Support Level $49.35 $0.01
Resistance Level $53.99 $0.02
Average True Range (ATR) 0.57 0.00
MACD -0.06 0.00
Stochastic Oscillator 44.22 10.48

Price Performance

Historical Comparison
SOMN
WGSWW

About SOMN Southern Company (The) 2025 Series A Corporate Units

Southern is one of the largest utilities in the US. The company serves 9 million customers with vertically integrated electric utilities in three states and natural gas distribution utilities in four states. It owns 44 gigawatts of rate-regulated generating capacity, primarily for serving customers in Georgia, Alabama, and Mississippi. Subsidiary Southern Power owns 13 gigawatts of natural gas generation and renewable energy across the US and sells the electricity primarily under long-term contracts.

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: